Additive-aggravated assays: An authoritative answer

Clinical Chemistry

Volumn 51, Issue 10, 2005, Pages 1767-

  Kricka, Larry J ^a   Park, Jason Y ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; HERBACEOUS AGENT;

BLOOD SAMPLING; CLINICAL LABORATORY; DESORPTION; EDITORIAL; IMMUNOASSAY; POLYACRYLAMIDE GEL ELECTROPHORESIS; QUALITY CONTROL;

ANTIBODIES; BLOOD SPECIMEN COLLECTION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOASSAY; ORGANOSILICON COMPOUNDS; SENSITIVITY AND SPECIFICITY; SODIUM DODECYL SULFATE; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS; TRIIODOTHYRONINE;

EID: 25444494134     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.057885     Document Type: Editorial

References (19)

1. Selby C. Interference in immunoassay. Ann Clin Biochem 1999;36:704-21.
2. Walker PL, Cawood ML, Earth JH. Interference in immunoassay is an underestimated problem. Ann Clin Biochem 2002;39:366-73.
3. Klee GG. Interferences in hormone immunoassays. Clin Lab Med 2004;24: 1-18.
4. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999;45:942-56.
5. Levinson SS, Miller JJ. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta 2002;325:1-15.
6. Diamandis EP. Immunoassay interference: a relatively rare but still important problem. Clin Biochem 2004;37:331-2.
7. Weber TH, Kapyaho KI, Tanner P. Endogenous interference in immunoassays in clinical chemistry. A review. Scand J Clin Lab Invest Suppl 1990; 201:77-82.
8. Emerson JF, Ngo G, Emerson SS. Screening for interference in immunoassays. Clin Chem 2003;49:1163-9.
9. Preissner CM, Dodge LA, O'Kane DJ, Singh RJ, Grebe SK. Prevalence of heterophilic antibody interference in eight automated tumor marker immunoassays. Clin Chem 2005;51:208-10.
10. Marks V. False-positive immunoassay results: a multicenter survey of erroneous immunoassay results from assays of 74 analytes in 10 donors from 66 laboratories in seven countries. Clin Chem 2002;48:2008-16.
11. Ismail AAA. A radical approach is needed to eliminate interference from endogenous antibodies in immunoassays. Clin Chem 2005;51:25-6.
12. Bowen RA, Chan Y, Cohen J, Rehak NN, Hortin GL, Csako G, et al. Effect of blood collection tubes on total triiodothyronine and other laboratory assays. Clin Chem 2005;51:424-33.
13. Bowen RAR, Chan Y, Ruddel ME, Hortin GL, Csako G, Demosky SJ Jr, et al. immunoassay interference by a commonly used blood collection tube additive, the organosilicone surfactant Silwet L-720. Clin Chem 2005;51: 1874-82.
14. Becton-Dickinson™. Technical bulletins VS7313 and VS7340. http:// bd.com/vacutainer/techbulletins/ (accessed July 2005).
15. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337-44.
16. Chow L, Johnson M, Wells A, Dasgupta A. Effect of the traditional Chinese medicines Chan Su, Lu-Shen-Wan, Dan Shen, and Asian ginseng on serum digoxln measurement by Tina-quant (Roche) and Synchron LX system (Beckman) digoxin immunoassays. J Clin Lab Anal 2003;17:22-7.
17. Datta P, Dasgupta A. Effect of Chinese medicines Chan Su and Danshen on EMIT 2000 and Randox digoxin immunoassays: wide variation in digoxin-like immunoreactivity and magnitude of interference in digoxin measurement by different brands of the same product. Ther Drug Monit 2002;24:637-44.
18. Dasgupta A, Actor JK, Olsen M, Wells A, Datta P. In vivo digoxin-like immunoreactivity in mice and interference of Chinese medicine Danshen in serum digoxin measurement: elimination of interference by using a chemiluminescent assay. Clin Chim Acta 2002;317:231-4.
19. Wahed A, Dasgupta A. Positive and negative in vitro interference of Chinese medicine dan shen in serum digoxin measurement. Elimination of interference by monitoring free digoxin concentration. Am J Clin Pathol 2001;116:403-8.